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This paper describes the development of synthetic biology as a distinct entity from current 
industrial biotechnology and the implications for a future based on its concepts.  The role of 
the engineering design cycle, in synthetic biology is established and the difficulties in making 
and exact analogy between the two emphasised.   It is suggested that process engineers can 
offer experience in the application of synthetic biology to the manufacture of products which 
should influence the approach of the synthetic biologist.   The style of teaching for synthetic 
biology appears to offer a new approach at undergraduate level and the challenges to the 
education of process engineers in this technology are raised.   Possible routes to the 
development of synthetic biology teaching are suggested.    
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1. Introduction 
In a recent paper (Hall and Howe, 2010) it was argued that a new paradigm for chemical 
engineering might be imminent based on a move from a reliance on fossil sources for basic 
chemicals to reliance on bio-based raw materials which would be renewable and thus 
sustainable.  In tandem with this change was the prospect of a combination of engineering 
principles and biology, under the name synthetic biology, which would synthesise biological 
systems with entirely novel functions beyond current biotechnology.  Given the potential 
impact of these changes this paper takes these concepts and investigates their significance for 
process engineering and the education of the next generation of chemical engineers.   
2. What is Synthetic Biology? 
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Engineering and biology have gone hand-in-hand for a long time: developing from early food 
fermentations, particularly brewing and baking, through to modern industrial biotechnology 
using whole organisms or enzyme extracts to produce products such as antibiotics and 
functional food components.   These activities have also brought about a good understanding 
of the physiology, growth characteristics and genetics of the organisms involved, such as 
Penicillium spp, Aspergillus spp, Saccharomyces cerevisiae and Escherichia coli which could 
be manipulated for greater expression of natural or recombinant products.   However, the 
genetic manipulation of these organisms in current biotechnology is considered to be ad hoc 
or serendipitous at best whereas synthetic biology offers the promise of specific design for 
purpose (European Commission, 2005). 
Although it has grown from the engineering/biology axis other fundamental advances in a 
third sphere have enabled synthetic biology to become nearer to reality.  These developments 
have been in the fusion of mathematics, computer modelling and information storage, 
retrieval and communication which have enabled complex biological systems to be mapped, 
quantified and masses of data transmitted as necessary.  Table 1 gives a list of the 
contributing disciplines and their individual roles in synthetic biology.  As a result of the 
potential control which can be achieved there are great claims for synthetic biology in 
fulfilling the promises which conventional biotechnology has not delivered to date.  Table 2 
gives a list of the broad areas of activity with specific applications within these areas.  The 
list is pretty all-encompassing with no area of current commercial activity (and by extension 
process engineering) omitted.  Immediate goals are the next generation of biofuels which are 
capable of driving the high-fuel usage sectors of heavy haulage, railways and aviation where 
current biofuels are not sufficiently energy-rich.  Another area of immediate impact could be 
in the production of drugs and pharmaceuticals such as the production of the antimalarial 
drug (artemisinin) precursor, artemisinic acid in engineered yeast (Ro et al., 2006).  This 
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offers an alternative route to its extraction from the medicinal plant, where limited 
availability is reflected in price, and a shift from plant to microbial production would give a 
reliable and affordable supply (Zeng et al., 2008).  This project was supported by the Bill and 
Melinda Gates Foundation, addresses a massive health issue and, being near to fruition and 
thus attracts the headlines for synthetic biology.  However, other potential applications of SB 
as listed in Table 2 may come to the fore such as the current emphasis on the production of 
biofuels.  
Synthetic biology is also of great public interest because it deals in the fundamentals of life 
with concomitant ethical, security and safety issues.  The successful sequencing of the human 
genome (International Human Genome Sequencing Consortium, 2001, Venter et al., 2001) 
gave synthetic biology another media boost but also raised, in the eyes of some observers,  
the spectre of, “Frankenstein”, organisms with malign uses or, at the very least, the threat of 
accidental release into the environment.   Thus, this eye-catching and newsworthy disciple 
has been the subject of debate far removed from academia (Specter, 2009) which, in turn, has 
brought about calls for regulation by bodies other than the active synthetic biology 
community itself.  Alongside the scientific discovery goes great commercial potential and 
fears for a profit-driven monopoly of multinational companies who can afford to fund the 
initial research and the sources of biomass on which they will be founded (Action Group for 
Erosion, Technology and Concentration, 2010).  The replacement of natural sources of bio-
active compounds (such as for antimalarial compound artemisinin mentioned above) could 
also deprive developing countries of revenue (Balmer and Martin, 2008).     
 The pace of progress in certain aspects of synthetic biology has been rapid with the first 
synthetic organism, from the poliovirus genome (7,741 base pairs), taking two years of work 
(Cello et al., 2002) whilst the genome of the bacteriophage ΦX-174 (5,386 base pairs) took 
just two  weeks to assemble in the J Craig Venter Institute  (Smith et al., 2003).  However, 
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this latter achievement reflects the sustained effort of a large group of researchers underlining 
the challenging nature of the field.   The first bacterium to be synthesised (also by the Venter 
Institute) was Mycobacterium genitalium with 589,000 base pairs (Gibson et al., 2008). This 
opened up the concept of a minimal cell which could be the, “blank”, canvas for engineering 
produced by removing genes which are not essential for life.  The minimal cell would have 
the minimum number of components to support biological synthesis from inserted DNA 
material and be viable.  M genitalium carries 485 genes, the smallest genome in laboratory 
organisms, and about one quarter (115 or more) could be removed with no effect on genome 
functionality in the laboratory although the organism would be unlikely to survive in the 
natural environment.  More conventional microbial carriers (or, “chassis”) for synthetic 
biology include E coli, yeasts, Bacillus subtilis and Pseudomonas putida reflecting the wide 
knowledge about these organisms built up over the years.  Future developments could include 
cell-free applications where the non-specific elements of the living cell chassis are removed 
from the application.   
With synthetic biology being based on the manipulation of genetic material there is the added 
issue of the Intellectual Property rights (IPR) for the new life forms created.   The minimal 
cell based on M genitalium synthesised by the Venter research group (and dubbed M 
laboratorium) was the subject of a patent application although the concept of patenting life 
forms is being challenged.  This application has at least opened up the debate over 
synthesised organisms and is likely to be the first of many such patent applications.   The 
models for the development of the synthetic biology-based industry could follow a variety of 
routes and may learn lessons from evolution of the fast-changing computing and software 
industry (Henkel and Maurer, 2007).   
3. Interaction of synthetic biology with  chemical engineering 
6 
 
Table 1 includes the contribution of the engineering design cycle approach to the 
development of synthetic biology.  The use of standard parts to build functional units/circuits 
in Electronic Engineering is a common analogy for SB where the standard parts are the basic 
biochemical elements which build modules to regulate, for example, gene behaviour and 
protein function (Purnick and Weiss, 2009) .    Similarly, chemical engineers are well versed 
in taking concepts from the chemistry and biochemistry fields and converting them into 
industrial scale processes through the engineering design cycle and subsequent building and 
commissioning stages.  Plant design also involves putting together a multitude of standard 
parts and unit operations into the most efficient system through an iterative process – 
recognising that a number of designs and process routes might be feasible practically but not 
from a commercial point of view.   Learning the art of process design is at the very core of 
chemical engineering education being the culmination of the separate disciplines which make 
up the subject.  Thus, process design is based on fundamental concepts such as heat and mass 
transfer, transport phenomena, reaction kinetics and modelling and fluid mechanics.  The 
basic principles for the process in question are then broken down into the unit operations 
which comprise the complete process and described in block flow diagrams, process flow 
diagrams and piping and instrumentation diagrams.  Other considerations include product 
throughput and quality; financial constraints and process criteria such as safety, flexibility 
and operational characteristics.  All this knowledge can be applied to synthetic biology in the 
consideration of what route to take to production.  The analogy between (chemical) 
engineering design and synthetic biology has been writ large in that the idea of taking 
discrete and standardised genetic units and putting them together to make an engineered 
organism is as direct or simple as in the physical world.  The goal would be a world in which 
the genetic information is recognised and the separate constructs are put together by genomic 
sequencing which delivers the exact requirements of the process in mind.    One approach to 
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the provision of these standard parts is the Biobricks Foundation which is a public-benefit 
organisation originating from workers at the Massachusetts Institute of Technology (MIT), 
Harvard and University of California, San Francisco.  The declared aim of the foundation is 
to make freely available the fundamental components, or bioparts, needed to conduct 
synthetic biology and in doing so to introduce the mindset which underpins, for example, 
chemical engineering design (Biobricks Foundation, 2011).       
However, the devil is in the detail for SB because the discrete standardised genetic units are 
not physical entities but biochemical units linked and controlled by biochemical regulation 
and hence prone to variation.  Just as a physical chemical plant must be coaxed into an 
operational equilibrium so the genomic components of a synthesised organism must be 
brought together carefully to function correctly and there has been an evolution in the 
complexity and scale at which this can be done (Andrianantoandro et al., 2006, Canton et al., 
2008, Purnick and Weiss, 2009).  In this respect the fuzzy aspects of chemical plant design 
could provide a good lesson to the synthetic biology discipline.  Many chemical processes are 
difficult to control automatically because of nonlinearity, time-variable behaviour and 
poor/non-existent measurement of important parameters and human operator experience 
becomes crucial in these situations.  Such processes include: catalytic cracking in petroleum 
refining, oil and gas separations, food processing, bio-reactors, crystallisation and in safety 
analysis.  Fuzzy logic, and associated systems, can be applied to those processes where the 
complexity is such that the ability to be precise about behaviour diminishes and 
approximations must be made.  Fuzzy logic allows such approximations through the 
development of knowledge-based systems (Emami, 2010).    The emphasis put on empiricism 
in teaching SB (see section 4) and the rapid accumulation of practical knowledge in SB 
would suggest that a fuzzy logic approach to genetic manipulation would be a fair gift from 
the chemical engineering discipline.               
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A second, more practical, input from the chemical engineering fraternity to synthetic biology 
could be in defining the processability of engineered organisms and their products.  Currently 
synthetic biology seems to be directed towards the genetic control of the organism for 
specific product expression but a substantial element in the cost of bio-products is their 
separation and purification – downstream processing (DSP).  Here the chemical engineer 
could ask the question about processability and define the DSP characteristics required in the 
final design.  This issue is being addressed in some instances, for example the use of E coli to 
produce biofuels which are expressed externally and, being immiscible with the aqueous 
fermentation broth, can be separated off easily.  Where products are expressed and water 
soluble it may be possible to select for ease of DSP, for example, by developing organisms 
which require a minimal/simple fermentation medium which can be easily removed in the 
early/high volume stages of DSP.   The minimal cell, with much genetic material removed 
yet viable in a simple growth medium, would be a good model for this approach.  Where 
products are expressed as internal inclusion bodies they must be separated from the cell 
contents.   Ways to achieve this separation would be helped by simple cell biochemistry and 
susceptibility to cell disruption paving the way for separation of the cell contents and the 
inclusion body.      
 
4. Education in synthetic biology 
 The time taken to teach all the required aspects of chemical engineering has lead to the 
modern degree with a curriculum as described in Table 3 (Hall and Howe, 2010).  Other 
aspects of a university degree have always been prominent in chemical engineering education 
such as problem solving and the modern chemical engineer with good mathematical ability 
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and literacy, combined with the ability to communicate with those from a range of 
disciplines, has much to offer the development of a synthetic biology discipline.   
However, bringing together as it does biology and engineering, synthetic biology is 
considered by some to be interdisciplinary and as such it falls into the uneasy territory 
between the two separate disciplines.  It is notable that the leading lights in synthetic biology, 
whether from engineering or a biology background, have embraced the other discipline and 
recognising the contribution it makes to their own expertise.   Such magnanimity towards an 
alien discipline appears to be an essential for synthetic biology to flourish.  This might 
suggest that an undergraduate course in synthetic biology would be difficult to construct and 
it would be better given at postgraduate level once students have a sound grounding in their 
favoured discipline and are mature enough in outlook to take on, “the new”.  Additionally, 
given the synthetic biology is still in its infancy it seems appropriate that teaching is taking 
place at the postgraduate Masters level with a joint intake of biologists and engineers.  Such 
courses could then lead students into PhD studies in the discipline.  However, as with any 
emerging discipline, there is an almost instant demand that synthetic biology be taught at the 
undergraduate level in its own right and that its important characteristics are taught to closely 
aligned courses such as chemical engineering.  
As with the research activity, the teaching of synthetic biology has been concentrated in the 
USA and the EU (with the UK to the fore) although centres in Japan, China and India are also 
springing up (RAE, 2009).  Imperial College, London in the UK was the first European 
university to offer synthetic biology at undergraduate and postgraduate levels and at the 
undergraduate level this comprises a final year module offered to biologists/biochemists and 
bioengineers.   In the USA, several universities (MIT, Harvard, Princeton, Stanford and the 
University of California, for example) are developing full synthetic biology undergraduate 
courses and many others offer components which could be the foundation of synthetic 
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biology studies.  The concept of discipline hopping has been introduced in recent years for 
academic staff to allow them to get a taste of other subject areas and to understand the 
working culture of  another discipline and this could be applied equally well to 
undergraduates, but probably outside the confines of their core timetable (RAE, 2009).  In 
this context, the iGEM (International Genetically Engineered Machine competition) held at 
MIT in the Summer holidays has been very successful in raising the profile of synthetic 
biology.  Undergraduate multidisciplinary teams from universities across the world have to 
design and build a functioning biological device for a range of practical applications in 
competition and, in doing, so develop new thinking and experiences beyond the conventional 
classroom.  The number of student groups and countries taking part has increased year on 
year (RAE, 2009) and is a clear demonstration that teaching an interdisciplinary subject can 
demand unorthodox approaches.   
Kuldell (2007) described the emergence of synthetic biology teaching to undergraduates at 
MIT and argued that the newness of the discipline militated against a traditional teaching 
approach because much of the framework and competencies required were still being 
developed.  However, it did give the opportunity to develop student innovation and creativity, 
which in turn, would produce flexible thinkers able to grapple with the complex issues 
thrown up by the application of synthetic biology in the real world.    Kuldell (2007) also 
argues that synthetic biology although being an amalgam of biology and engineering should 
not automatically be labelled, “interdisciplinary”.  Synthetic biology demands that its 
practitioners think and work differently to, “engineers”, or, “biologists”, confronted by the, 
“other”, discipline.   In this context, the sooner a student embraces synthetic biology with all 
its uncertainties and real world connotations the better and a full undergraduate course may 
be the way to achieve this and may appeal to the maverick soul who can appreciate the 
challenges inherent in the discipline.   Dymond et al., (2009) described undergraduate 
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teaching in synthetic biology at Johns Hopkins University from a geneticist’s point of view.  
The Build-a-Genome course included introductory lectures on genetics then bioinformatics 
and also the economics and ethical issues associated with synthetic biology.  Laboratory-
based sessions were a central feature and included basic molecular biology techniques 
followed by synthetic gene assembly in yeast.  The emphasis was on independent research, 
problem solving and creativity and where appropriate for students to follow up side projects 
on problems thrown up during the course of the practical work.  The evolution of the Build-a-
Genome course also highlighted the considerable staffing, practical and physical resources 
and financial support which are necessary to teach innovative material to undergraduates and 
the course was costed at US$30,000 for one semester for less than 20 students.  A feature of 
both the MIT and Johns Hopkins teaching is the emphasis on undergraduates performing 
research-lead activities which could lead to commercial products and publishable work.          
Given this background strategies for teaching synthetic biology to career chemical engineers 
could follow three routes: 
integration of synthetic biology concepts into existing courses in the final year (as done 
by Imperial College, London) but and only for high-level students? 
mixed teaching with interdisciplinary courses from non-engineering departments (akin 
to discipline hopping) 
dedicated synthetic biology undergraduate courses attracting engineering-orientated 
and biology-orientated students with a high degree of research-led activity. 
All three approaches have their merits and their adoption could be dependent on the particular 
circumstances at any teaching institution. 
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An integrated approach would ensure that all chemical engineering students were aware of 
synthetic biology and those wishing to specialise in the discipline could do so in the later 
stages of an undergraduate course and particularly at the postgraduate level.   The demands of 
a conventional chemical engineering course with its design and problem solving content 
would be a good grounding for such postgraduate study.   Mixed teaching would allow 
engineers to discipline hop and the hands-on training such as through the iGEM and Build-a-
Genome models can be fitted in around a conventional engineering course.   The dedicated 
course offers the longest and most thorough teaching in synthetic biology, perhaps over four 
years, but would require careful marketing to attract the students who would embrace the 
unique challenges, both intellectual and practical, in mastering the biology/engineering 
disciplines.   From the examples cited here a dedicated course does offer the chance for 
undergraduate students to be real stakeholders in innovation, to drive the subject forward and 
become critical thinkers and decision makers in the process.   However, a dedicated course 
over a full undergraduate degree period of four years may lose the immediacy generated by 
the mixed approach where short bursts of intense practical activity support teaching in the 
student’s favoured discipline.  
5. Possible strategy for teaching synthetic biology to engineers 
A further strategy for teaching synthetic biology to engineers is shown in Figure 1 which can 
be described as an integrated- mixed approach.   Students following the integrated route will 
follow the basic chemical engineering course building up their expertise and interest in 
synthetic biology along the way with the option of a final year project in the subject.  
Students following the mixed route will receive the basic integrated course with the addition 
of out-of-session courses for a more intensive experience – enhanced by having the most 
challenging and exciting hands-on experience in the first instance.   For engineering students 
the challenging aspects would be the practical skills of molecular biology and genome 
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synthesis whilst the informatics and communications should be taken up more easily.  This 
approach will put an extra burden on the mixed route students but with the bonus of a 
thorough grounding in the discipline which could lead directly to PhD-level studies or 
employment in the sector.   These combinations could also lead to a dedicated synthetic 
biology course with a strong engineering emphasis depending on the focus and expertise 
available at each academic institution.  If the unique feature of synthetic biology is the hands-
on, critical thinking and real-life scenarios experienced by undergraduate students there is no 
need, or indeed expectation, that all synthetic biology courses fit the same mould and perhaps 
no need for a dedicated course in the field.   As with any established discipline a number of 
core competences will emerge and all synthetic biology courses will incorporate them but the 
individuality of teaching at any one institution must remain. 
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